SEC Form 4 · accession 0001815638-26-000011
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thane Wettig
Officer — CEO · Director
Period of report
Sep 6, 2026
Accepted (ET)
Sep 9, 2026 · 8:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 6, 2026 | F | 209 | $8.55 | D | 26,796 | D | |
| Common Stock | holding | — | — | — | 40 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units